Live tape
Top 8, mentions 7d11,135GOOGL2,270 mentions▲ +0.03HTZ1,729 mentions▲ +0.10SPCX1,513 mentions▲ +0.08NBIS1,435 mentions▲ +0.10SNDK1,341 mentions▲ +0.11NVDA1,187 mentions▲ +0.09MSFT886 mentions▲ +0.06META774 mentions▲ +0.03

Equity · Healthcare

IQV

IQVIA Holdings Inc. · NYSE

$206.17 −2.29% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart
Our own end-of-day closes 41 sessions
$220 $160 19 May 17 Jul

The line runs $173 on 19 May through $206.17 on 17 July, on a scale from $160 to $220. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of IQV over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 41 sessions over that window: $173 on 19 May 2026 through $206.17 on 17 July 2026.

Market cap $34.4B
P/E (TTM) 31.8
52-week range $157 – $244.30
Avg volume 350.8K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 17, 2026

IQV insider trades

SEC Form 4 · last 90 days · newest reported trade 3 Aug 2026
Open-market buys 0
Open-market sells 5
Net sold $29.19M
Non-trade filings 2
Date Insider Type Shares Value
03 Aug 2026 STAUB W RICHARD See Remarks Sell 5,500 $1.28M
31 Jul 2026 Patel Bhavik See Remarks Sell 1,855 $436K
29 Jul 2026 BOUSBIB ARI See Remarks Sell 106,279 $26.09M
29 Jul 2026 Cherofsky Keriann See Remarks Sell 558 $137K
29 Jul 2026 Sherbet Eric See Remarks Sell 5,000 $1.25M

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
29 Jul 2026 BOUSBIB ARI See Remarks Option exercise 156,206 $12.22M
29 Jul 2026 BOUSBIB ARI See Remarks Other 49,927 $12.22M

IQV reported financials

SEC EDGAR XBRL

IQV reported revenue of $16.3B for the fiscal year ended 31 Dec 2025. Net income over the same period was $1.4B.

Figure Reported Period
Revenue $16.3B 31 Dec 2025 fiscal year
Net income $1.4B 31 Dec 2025 fiscal year
Diluted EPS $7.84 31 Dec 2025 fiscal year
Total assets $29.7B 31 Mar 2026 at period end
Total equity $6.2B 31 Mar 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026

IQV earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $1.61 —
31 Dec 2025 FY 2025 $7.84 —
30 Sep 2025 Q3 2025 $1.93 —
30 Jun 2025 Q2 2025 $1.54 —
31 Mar 2025 Q1 2025 $1.40 —
31 Dec 2024 FY 2024 $7.49 —
30 Sep 2024 Q3 2024 $1.55 —
30 Jun 2024 Q2 2024 $1.97 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

IQV institutional holders

SEC Form 13F

12 of the 45 institutional funds we track reported a IQV position for the quarter ended 30 Jun 2026 — a combined $823.4M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
AQR Capital Management Held (±25%) +23.9% shares 1,536,874 $297.0M
Balyasny Asset Management Added +27,573.8% shares 700,425 $135.3M
Millennium Management Added +92.7% shares 516,724 $99.8M
D. E. Shaw & Co. New position 466,234 $90.1M
Man Group Added +1,356.0% shares 295,679 $57.1M
Point72 Asset Management New position 279,468 $54.0M
Citadel Advisors Trimmed −41.2% shares 229,366 $44.3M
Tudor Investment Corp New position 119,544 $23.1M
Two Sigma Investments Trimmed −78.1% shares 48,191 $9.3M
Marshall Wace Added +10,362.8% shares 37,666 $7.3M

Showing the 10 largest of 12 reported positions. The figures above count all of them.

Source: SEC EDGAR 13F filings

IQV fails-to-deliver

SEC CNS data

On 10 Jul 2026, 212 shares of IQV failed to deliver (about $44K).

Settlement date Shares failed Notional % of shares out
10 Jul 2026 212 $44K <0.001%

Source: SEC fails-to-deliver (CNS) data